Sunday, March 12, 2023 5:27:19 PM
Keep in mind the virus also forces the body to produce virus cells with lots of spike proteins.
Not just the vaccine. The difference is that vaccine spikes to not attack and enslave human cells turning the infected cells into WMD's that mass produce the virus.
Both wake up the immune system to make antibodies.
Some antibodies mass produce WMD's, the most deadly ones on the planet, known as Super Oxide Anion. It is the most powerful oxidant known to man. It damages genes and DNA and that damage can lead to cancer...
One of the regenerable, mother of all antioxidants is Glutathione, which Bucillamine regenerates, and it is 16 times more active than "NAC" and it neutralizes excess Super Oxide Anion.
It also is a safe blood clot buster, that we know will work for most all autoimmune diesease thanks to recent discoveries we shared here several months ago. And it helps block Covid19 cell infection... Safely!!!
Not just the vaccine. The difference is that vaccine spikes to not attack and enslave human cells turning the infected cells into WMD's that mass produce the virus.
Both wake up the immune system to make antibodies.
Some antibodies mass produce WMD's, the most deadly ones on the planet, known as Super Oxide Anion. It is the most powerful oxidant known to man. It damages genes and DNA and that damage can lead to cancer...
One of the regenerable, mother of all antioxidants is Glutathione, which Bucillamine regenerates, and it is 16 times more active than "NAC" and it neutralizes excess Super Oxide Anion.
It also is a safe blood clot buster, that we know will work for most all autoimmune diesease thanks to recent discoveries we shared here several months ago. And it helps block Covid19 cell infection... Safely!!!
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
